Data presented by Hiby et al. confirmed that maternal inhibitory KIR2DL1 was associated with pregnancy disorders linked to inadequate placentation, and it negatively impacted fetal body weight [40]. This evidence concerns the gene KIR2DL1 and pregnancy disorder.